 |
|
|
|
|
|
|
|
|
|
|
|
1 to 29 of 29 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Walsh D. on PAPER: Balducci C. et al., 2010, This is an interesting study that addresses two important issues relating to the role of Aβ in... 26 Jan 2010.
|
|
|
 |
|
|
Walsh D. on SITE POLL: Are you in favor of ICAD going annual?, I don't think an annual conference is a good idea. Having more frequent meetings won't speed up... 12 Nov 2008.
|
|
|
|
|
|
Walsh D. on PAPER: Luheshi LM. et al., 2007, Homing In on the Molecular Determinants of Aβ Assembly and Toxicity: Lessons from the... 5 Nov 2007.
|
|
|
|
|
|
Walsh D. on PAPER: Grant MA. et al., 2007, Aβ Takes a Turn for the Better?
Using a powerful combination of biochemistry,... 18 Oct 2007.
|
|
|
|
|
|
Walsh D. on NEWS: Role Reversal—AD Mouse Desperately Seeks CatB, This is an extensive and very carefully controlled study in which the authors demonstrate that... 24 Sep 2006.
|
|
|
|
|
|
Walsh D. on NEWS: Aβ Star is Born? Memory Loss in APP Mice Blamed on Oligomer, This study is impressive both for the breadth and detail of the experiments undertaken. Using... 21 Mar 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Soba P. et al., 2006, Recommendation Only. 13 Feb 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Stokin GB. et al., 2006 Mar-May, Recommendation Only. 13 Feb 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Ma QL. et al., 2006, An interesting study that suggests a link between Abeta oligomers, GSK-3beta and tau... 14 Jan 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Maat-Schieman M. et al., 2005, An excellent overview of the pathology of an understudied AD-related disease. 6 Jan 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Rovelet-Lecrux A. et al., 2006, Recommendation Only. 4 Jan 2006.
|
|
|
|
|
|
Walsh D. on PAPER: Cirrito JR. et al., 2005, Recommendation Only. 30 Dec 2005.
|
|
|
|
|
|
Walsh D. on PAPER: Han P. et al., 2005, Recommendation Only. 30 Dec 2005.
|
|
|
|
|
|
Walsh D. on NEWS: Paper Alert: Synaptic Activity Increases Aβ Release, Recommendation Only. 30 Dec 2005.
|
|
|
|
|
|
Walsh D. on PAPER: Neumann S. et al., 2006, So long forgotten, interest in the APLPs is slowly growing. This
paper clearly demonstrates... 20 Dec 2005.
|
|
|
|
|
|
Walsh D. on PAPER: Maloney MT. et al., 2005, In this paper the authors provide compelling data demonstrating that
low concentrations (10 nM... 20 Dec 2005.
|
|
|
|
|
|
Walsh D. on NEWS: Atorvastatin, Vaccine Trial Data Published, The analysis of a subset of patients for whom CSF samples were available before and after... 16 May 2005.
|
|
|
|
|
|
Walsh D. on NEWS: Varicose Axons: Traffic Jams Precede AD Pathology in Mice, Men, This excellent study clearly demonstrates that axonal damage occurs long
before amyloid... 21 Mar 2005.
|
|
|
|
|
|
Walsh D. on PAPER: Domínguez-del-Toro E. et al., 2004, This study is in good agreement with earlier work by 6 Oct 2004.
|
|
|
|
|
|
Walsh D. on NEWS: FRETting Pays off—NSAIDs Target Presenilins, Reduce Aβ42, Allosteric modulation of γ-secretase activity offers a new avenue for specific inhibition of... 1 Oct 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Cao X. et al., 2001, A landmark paper demonstrating that APP intracellular domain is involved in transcriptional... 28 Jun 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Nilsberth C. et al., 2001, A landmark paper, which suggests that soluble oligomeric forms of Aβ initiate disease. 28 Jun 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Lewis J. et al., 2001, One of the most important papers of 2001. Along with Gotz, et al.,
this paper demonstrated a... 28 Jun 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Weggen S. et al., 2001, The most innovative paper from 2001, which provided a novel means of
modulating γ-secretase... 28 Jun 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Götz J. et al., 2001, One of the most important papers of 2001. Along with Lewis, et al.,
this paper demonstrated a... 18 Jun 2004.
|
|
|
|
|
|
Walsh D. on PAPER: Ho A. et al., 2004, The function of APP remains unknown, but it has long been assumed that APP is a receptor.... 27 Feb 2004.
|
|
|
|
|
|
Walsh D. on NEWS: Amyloid Oligomer Antibody—One Size Fits All?, The paper by Kayed et al. describes the development, characterization, and use of a reagent that... 23 Apr 2003.
|
|
|
|
|
|
Walsh D. on NEWS: Fog Beginning to Clear on Aβ-Degrading Enzymes?, Aβ-degrading enzymes—many candidates, but few fit the bill
This comment extends the news... 20 Nov 2001.
|
|
|
|
|
|
Selkoe D, Walsh D. on LIVE DISCUSSION: Intracellular Aβ in Alzheimer's Disease, From various studies examining the toxicity of Aβ,
it is clear that random coil monomeric Aβ... 15 May 2000.
|
|
|
|
|
|
|
1 to 29 of 29 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
